Evolent Health | 10-Q:季度报表
Evolent Health | 8-K:Evolent 公布 2024 年第一季度业绩
Evolent Health | ARS:年度报告
Evolent Health | DEFA14A:其他
Evolent Health | DEF 14A:股东委托书决议
Evolent Health | 4:持股变动声明-高管 Tutewohl Steve
Evolent Health | SC 13G/A:超过5%持股股东披露文件(修正)-JPMORGAN CHASE & CO.(4.0%)
Evolent Health | 4:持股变动声明-董事 Glass Russell Monroe
Evolent Health | 4:持股变动声明-高管 Rafferty Emily Ann
Evolent Health | 4:持股变动声明-高管 Shams Aammaad
Evolent Health | 4:持股变动声明-高管 Weinberg Jonathan
Evolent Health | 4:持股变动声明-高管 Johnson John Paul
Evolent Health | 4:持股变动声明-高管 Blackley Seth
Evolent Health | 4:持股变动声明-高管 McCarthy Daniel Joseph
Evolent Health | 3:首次持股声明-董事 Glass Russell Monroe
Evolent Health | 4:持股变动声明-高管 McCarthy Daniel Joseph
Evolent Health | 4:持股变动声明-高管 Blackley Seth
Evolent Health | 4:持股变动声明-高管 Johnson John Paul
Evolent Health | 4:持股变动声明-高管 Weinberg Jonathan
Evolent Health | 10-K:年度报表
暂无数据